UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

Annals of oncology, 2015-05, Vol.26 (5), p.894-901

2015

Volltextzugriff (PDF)

Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular Injury

The Annals of thoracic surgery, 2015-08, Vol.100 (2), p.487-493

2015

Volltextzugriff (PDF)

Forecasting the future demand on health workforce – the Austrian model

European journal of public health, 2024-11, Vol.34 (Supplement_3)

Rappold, E

2024

Volltextzugriff (PDF)

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation

British journal of clinical pharmacology, 2023-08, Vol.89 (8), p.2396-2406

2023

Volltextzugriff (PDF)

P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL LYMPHOMA (CITADEL‐112): PRELIMINARY SAFETY RESULTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.992-993

2022

Volltextzugriff (PDF)

The association of arterial blood pressure waveform-derived area duty cycle with intra-arrest hemodynamics and cardiac arrest outcomes

Resuscitation, 2023-10, Vol.191, p.109950-109950, Article 109950

2023

Volltextzugriff (PDF)

Advancing Dementia Care in Austria: developing a Dementia Registry using a multimethod approach

European journal of public health, 2024-11, Vol.34 (Supplement_3)

2024

Volltextzugriff (PDF)

0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer

Breast (Edinburgh), 2009, Vol.18, p.S58-S58

2009

Volltextzugriff (PDF)

TEACH phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-overexpressing breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.120-121

2008

Volltextzugriff (PDF)

Praxis der Ernährungstherapie bei stationären dementen Patienten

Aktuelle Ernährungsmedizin, 2004-04, Vol.29 (2), p.63-68

Rappold, E.

2004

Volltextzugriff (PDF)

"Permissive hypoventilation" in a swine model of hemorrhagic shock

The journal of trauma and acute care surgery, 2014-07, Vol.77 (1), p.14-19

2014

Volltextzugriff (PDF)

2009 POSTER Safety of the combination of lapatinib (L) plus trastuzumab (T) in patients (pts) with HER2-Positive (+) metastatic breast cancer (MBC)

European journal of cancer supplements, 2007, Vol.5 (4), p.187-187

2007

Volltextzugriff (PDF)

Abstract PD10-05: HLA-DQA102:01/DRB107:01 as a biomarker for lapatinib-induced hepatotoxicity: prospective confirmation in a large randomised clinical trial (TEACH, EGF105485)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD10-05-PD10-05

2012

Volltextzugriff (PDF)

HLA-DRB107:01-DQA102:01 and UGT1A128 allele carriage in hepatic serious adverse event cases identified during lapatinib clinical trials

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.547-547

2011

Volltextzugriff (PDF)

Hepatobiliary abnormalities in patients with metastatic cancer treated with lapatinib

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1043-1043

2009

Volltextzugriff (PDF)

S4-7: Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2-Overexpressing Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.S4-S4-7

2011

Volltextzugriff (PDF)

Hyperbilirubinemia in Lapatinib Treated Patients Is Associated with Gilbert's Syndrome UGT1A1 Polymorphism

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.1112-1112

2009

Volltextzugriff (PDF)

Hypotension After Cardiac Surgery Based on Autoregulation Monitoring Leads to Brain Cellular Injury

The Annals of thoracic surgery, 2015-06, Vol.100 (2), p.487-493

2015

Volltextzugriff (PDF)

Addressing restoration issues for the ISO New England system

2012 IEEE Power and Energy Society General Meeting, 2012, p.1-5

2012

Volltextzugriff (PDF)

Cardiac safety in patients (pts) with metastatic breast cancer (MBC) treated with lapatinib (L) and trastuzumab (TRA)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.514-514

2007

Volltextzugriff (PDF)

Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes

Journal of molecular medicine (Berlin, Germany), 2003-07, Vol.81 (7), p.435-442

2003

Volltextzugriff (PDF)

Treatment of polymorphous light eruption with nicotinamide: a pilot study

British journal of dermatology (1951), 1986-07, Vol.115 (1), p.77-80

1986

Volltextzugriff (PDF)

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.621-621

2004

Volltextzugriff (PDF)

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.621-621

2004

Volltextzugriff (PDF)

How do we experience our nursing education--what do we wish for?

Osterreichische Krankenpflegezeitschrift, 1991, Vol.44 Suppl, p.90

Rappold, E

1991

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Aktive Filter

KollektionPROLA

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Englisch
(275)
Deutsch
(5)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(166)
Life Sciences & Biomedicine
(132)
Humans
(123)
Female
(60)
Male
(55)
Biological And Medical Sciences
(48)
Adult
(36)
Genetics & Heredity
(35)
Medical Sciences
(35)
Physical Sciences
(26)
Air Pollution
(25)
Environmental Sciences
(25)
Physics
(25)
Environmental Sciences & Ecology
(24)
Middle Aged
(24)
Child
(21)
Homeodomain Proteins - Genetics
(21)
Animals
(20)
Aged
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular Injury

Forecasting the future demand on health workforce – the Austrian model

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation

P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL LYMPHOMA (CITADEL‐112): PRELIMINARY SAFETY RESULTS

The association of arterial blood pressure waveform-derived area duty cycle with intra-arrest hemodynamics and cardiac arrest outcomes

Advancing Dementia Care in Austria: developing a Dementia Registry using a multimethod approach

0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer

TEACH phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-overexpressing breast cancer

Praxis der Ernährungstherapie bei stationären dementen Patienten

"Permissive hypoventilation" in a swine model of hemorrhagic shock

2009 POSTER Safety of the combination of lapatinib (L) plus trastuzumab (T) in patients (pts) with HER2-Positive (+) metastatic breast cancer (MBC)

Abstract PD10-05: HLA-DQA102:01/DRB107:01 as a biomarker for lapatinib-induced hepatotoxicity: prospective confirmation in a large randomised clinical trial (TEACH, EGF105485)

HLA-DRB107:01-DQA102:01 and UGT1A128 allele carriage in hepatic serious adverse event cases identified during lapatinib clinical trials

Hepatobiliary abnormalities in patients with metastatic cancer treated with lapatinib

S4-7: Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2-Overexpressing Breast Cancer

Hyperbilirubinemia in Lapatinib Treated Patients Is Associated with Gilbert's Syndrome UGT1A1 Polymorphism

Hypotension After Cardiac Surgery Based on Autoregulation Monitoring Leads to Brain Cellular Injury

Addressing restoration issues for the ISO New England system

Cardiac safety in patients (pts) with metastatic breast cancer (MBC) treated with lapatinib (L) and trastuzumab (TRA)

Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes

Treatment of polymorphous light eruption with nicotinamide: a pilot study

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

How do we experience our nursing education--what do we wish for?

Aktive Filter

Suchergebnisse filtern